Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Clinical characteristics of congenital myotonic dystrophy diagnosed by molecular genetic method

분자 유전학적 방법으로 진단된 선천성 근육긴장성 이영양증 환자의 임상 양상

  • Nam, Sook Hyun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine) ;
  • Son, Young Bae (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine) ;
  • Lee, Bo Lyun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine) ;
  • Lee, Jeehun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine) ;
  • Ki, Chang-seok (Laboratory medicine, Samsung Medical Center, Sungkyunkwan University school of Medicine) ;
  • Lee, Munhyang (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University school of Medicine)
  • 남숙현 (성균관대학교 의과대학 삼성서울병원 소아과학교실) ;
  • 손영배 (성균관대학교 의과대학 삼성서울병원 소아과학교실) ;
  • 이보련 (성균관대학교 의과대학 삼성서울병원 소아과학교실) ;
  • 이지훈 (성균관대학교 의과대학 삼성서울병원 소아과학교실) ;
  • 기창석 (성균관대학교 의과대학 삼성서울병원 진단검사의학교실) ;
  • 이문향 (성균관대학교 의과대학 삼성서울병원 소아과학교실)
  • Received : 2007.06.15
  • Accepted : 2007.07.27
  • Published : 2007.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : We performed this study to investigate the perinatal and developmental features of the patients with congenital myotonic dystrophy (CDM) confirmed by the molecular genetic method and the clinical characteristics of their mother, and to identify the relation between the number of CTG repeats and the clinical severity.Methods : A retrospective review of the medical records and the results of the dystrophia myotonica protein kinase (DMPK) gene test was done for the patients who were confirmed as CDM through gene analysis from January 2001 to September 2006. Results : All of the eight patients (male 2, female 6) showed moderate to severe degree of perinatal distress and feeding difficulty associated with profound hypotonia. Three patients had the history of polyhydramnios and two patients had equinovarus deformity. The developmental milestones were delayed in all patients, which improved gradually with age. All of their mothers demonstrated myotonic symptoms and typical myopathic face. The number of CTG repeats in DMPK gene analysis ranged 1,000-2,083, and there was no significant correlation between the number of CTG repeats and the time of walking alone. Conclusion : All patients with CDM presented with severe hypotonia in perinatal period, and developmental delay thereafter, which were improved with age. All of their mothers manifested myotonic symptoms with typical myopathic face, and the identification of such features greatly contributed to the diagnosis of the patients. The number of CTG repeats had no significant influence on the motor development.

목 적 : 선천성 근육긴장성 이영양증(congenital myotonic dystrophy, CDM) 환자의 주산기 병력, 영아기 및 소아기의 증상, 그리고 환자 어머니의 임상양상을 확인하여, 임상진단에 도움이 될 수 있는 특징적인 소견과, DMPK유전자의 CTG 서열반복 수와 운동발달 관계를 확인하고자 하였다. 방 법 : 2001년 1월부터 2006년 9월까지 삼성서울병원에서 DMPK 유전자 검사를 통해 CDM으로 확진된 환자 8명(남자 2명, 여자 8명)을 대상으로 의무기록과 DMPK 유전자 검사를 후향적으로 분석하였다. 결 과 : 진단 시 환자들의 연령은 7일에서 45개월(중앙값: 20.5 개월)이었으며, 환자들은 발달지연, 수유곤란, 그리고 근육긴장저하를 주소로 내원하였다. 3명의 환자에서 산전 초음파 상 원인 불명의 양수과다증이 확인되었다. 모든 환자에서 운동발달지연이 있었으며, 연령이 증가할수록 호전되었다. 모든 환자들의 어머니에서 전형적인 근병증의 모습과 근육긴장증을 확인하였고, 4명의 환자에서는 어머니 형제의 가족력을 확인하였다. DMPK유전자의 CTG 서열반복 수는 1,000-2,083(중앙값: 1,533.5)의 분포를 보였으며, 운동발달 중 혼자 걷기의 지연 정도와 유의한 상관관계는 없었다. 1명의 환자에서 세대간 예견효과를 확인하였다. 결 론 : CDM 환자는 산전초음파에서 양수과다증, 내반첨족, 태동의 저하 등의 소견을 보이고, 출생 후 근육긴장저하와 연관된 호흡곤란, 수유곤란, 그리고 발달지연 등의 증상을 나타낸다. 모든 환자들의 어머니는 특징적인 근병증의 외양과 근육긴장증을 가지고 있어, 산모에 대해 이러한 소견을 확인하는 것이 산전진단에 중요한 단서가 된다. CDM에서 근육긴장저하와 연관된 증상은 연령이 증가할수록 호전되며, DMPK 유전자의 CTG 서열반복 수와 운동발달 중 혼자 걷기 시기 간의 유의한 연관은 없었다.

Keywords

References

  1. Harper PS, DG M. Myotonic dystrophy, in Engel AG, Franzini- Armstrong C (eds): Myology (ed3). In. New York: NY, McGraw Hill Professional, 2004:1039-76
  2. Harper PS. Myotonic Dystrophy. 2nd ed. London : W.B. Saunders, 1989:13-78
  3. Schara U, Schoser BG. Myotonic dystrophies type 1 and 2:a summary on current aspects. Semin Pediatr Neurol 2006; 13:71-9 https://doi.org/10.1016/j.spen.2006.06.002
  4. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18 https://doi.org/10.1002/mus.20301
  5. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992;255:1253-5 https://doi.org/10.1126/science.1546325
  6. Fu YH, Pizzuti A, Fenwick RG, Jr., King J, Rajnarayan S, Dunne PW, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-8 https://doi.org/10.1126/science.1546326
  7. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC). Neurology 2000;54:1218-21 https://doi.org/10.1212/WNL.54.6.1218
  8. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992;69:385
  9. Jung SH, Bang MS. Belated diagnosis of congenital myotonic dystrophy in a boy with cerebral palsy. Am J Phys Med Rehabil 2007;86:161-5 https://doi.org/10.1097/PHM.0b013e31802ee339
  10. Kim SH, Kim EY, Park SK, Choi SJ, Lim SC. A Case of Congenital Myotonic Dystrophy Diagnosed by Molecular Genetics. J Korean Soc Neonatol 2006;13:194-8
  11. Kim HK, Kim JH, Lee YA, Ko TS, Kim KS, Yoo HW, et al. A Case of Congenital Myotonic Dystrophy Diagnosed by Molecular Genetics. J Korean Child Neurol Soc 1998;5:356- 60
  12. Cho DH, Tapscott SJ. Myotonic dystrophy: Emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2006; 1772:195-204
  13. Zaki M, Boyd PA, Impey L, Roberts A, Chamberlain P. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007; 29:284-8 https://doi.org/10.1002/uog.3859
  14. Roig M, Balliu PR, Navarro C, Brugera R, Losada M. Presentation, clinical course, and outcome of the congenital form of myotonic dystrophy. Pediatr Neurol 1994;11:208-13 https://doi.org/10.1016/0887-8994(94)90104-X
  15. Furling D, Lam le T, Agbulut O, Butler-Browne GS, Morris GE. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy. Am J Pathol 2003;162:1001-9 https://doi.org/10.1016/S0002-9440(10)63894-1
  16. Lueck JD, Mankodi A, Swanson MS, Thornton CA, Dirksen RT. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J Gen Physiol 2007;129:79-94 https://doi.org/10.1085/jgp.200609635
  17. Dubowitz V. Genetic counselling. Neuromuscul Disord 1992; 2:85-6 https://doi.org/10.1016/0960-8966(92)90039-9
  18. Dubowitz V. Muscle Disorders in Childhood. 2nd ed. London: WB Saunders Co, 1995:289
  19. Rudnik-Schoneborn S, Zerres K. Outcome in pregnancies complicated by myotonic dystrophy: a study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol 2004;114:44-53 https://doi.org/10.1016/j.ejogrb.2003.11.025
  20. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993;52:1164-74
  21. Imbert G, Kretz C, Johnson K, Mandel JL. Origin of the expansion mutation in myotonic dystrophy. Nat Genet 1993; 4:72-6 https://doi.org/10.1038/ng0593-72
  22. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, Rabes JP, Duros C, Savoy D, et al. Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993;52:875-83
  23. Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy. Bioessays 1998;20:901-12 https://doi.org/10.1002/(SICI)1521-1878(199811)20:11<901::AID-BIES5>3.0.CO;2-0
  24. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005;6:729-42 https://doi.org/10.1038/nrg1689
  25. Arsenault ME, Prevost C, Lescault A, Laberge C, Puymirat J, Mathieu J. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006;66:1248-50 https://doi.org/10.1212/01.wnl.0000208513.48550.08
  26. Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005;15:5-16 https://doi.org/10.1016/j.nmd.2004.09.012
  27. Zerylnick C, Torroni A, Sherman SL, Warren ST. Normal variation at the myotonic dystrophy locus in global human populations. Am J Hum Genet 1995;56:123-30
  28. Martorell L, Cobo AM, Baiget M, Naudo M, Poza JJ, Parra J. Prenatal diagnosis in myotonic dystrophy type 1. Thirteen years of experience: implications for reproductive counselling in DM1 families. Prenat Diagn 2007;27:68-72 https://doi.org/10.1002/pd.1627
  29. Geifman-Holtzman O, Fay K. Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother: case report and literature review. Am J Med Genet 1998;78:250-3 https://doi.org/10.1002/(SICI)1096-8628(19980707)78:3<250::AID-AJMG8>3.0.CO;2-T